Eriko Simamura

628 total citations
22 papers, 532 citations indexed

About

Eriko Simamura is a scholar working on Molecular Biology, Toxicology and Immunology. According to data from OpenAlex, Eriko Simamura has authored 22 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Toxicology and 6 papers in Immunology. Recurrent topics in Eriko Simamura's work include Bioactive Compounds and Antitumor Agents (6 papers), ATP Synthase and ATPases Research (4 papers) and Paraquat toxicity studies and treatments (4 papers). Eriko Simamura is often cited by papers focused on Bioactive Compounds and Antitumor Agents (6 papers), ATP Synthase and ATPases Research (4 papers) and Paraquat toxicity studies and treatments (4 papers). Eriko Simamura collaborates with scholars based in Japan, United States and Italy. Eriko Simamura's co-authors include Kei‐Ichi Hirai, Hiroki Shimada, Toshihisa Hatta, Junko Koyama, Jiehong Pan, Nobuaki Higashi, Shigeomi Shimizu, Hiroki Otani, Yukie Niwa and Tsutomu Takegami and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Endocrinology.

In The Last Decade

Eriko Simamura

22 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eriko Simamura Japan 15 280 69 68 64 53 22 532
Emanuela Lafavia Italy 6 420 1.5× 24 0.3× 108 1.6× 27 0.4× 39 0.7× 7 779
Clotilde B. Angelucci Italy 12 157 0.6× 27 0.4× 35 0.5× 35 0.5× 51 1.0× 29 399
Chung‐Ho Chang United States 12 226 0.8× 80 1.2× 62 0.9× 21 0.3× 17 0.3× 20 423
Brian Cornblatt United States 9 537 1.9× 52 0.8× 42 0.6× 23 0.4× 59 1.1× 10 703
Margaret Moore United States 8 313 1.1× 16 0.2× 32 0.5× 31 0.5× 15 0.3× 12 1.0k
Guozhu Chen China 17 464 1.7× 57 0.8× 102 1.5× 18 0.3× 18 0.3× 29 780
Fabián Jaña Chile 13 348 1.2× 14 0.2× 28 0.4× 34 0.5× 15 0.3× 16 579
Toshikatsu Nakabayashi Japan 13 281 1.0× 11 0.2× 28 0.4× 54 0.8× 42 0.8× 37 461
Maie Al‐Bader Kuwait 16 290 1.0× 10 0.1× 59 0.9× 57 0.9× 38 0.7× 41 797

Countries citing papers authored by Eriko Simamura

Since Specialization
Citations

This map shows the geographic impact of Eriko Simamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eriko Simamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eriko Simamura more than expected).

Fields of papers citing papers by Eriko Simamura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eriko Simamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eriko Simamura. The network helps show where Eriko Simamura may publish in the future.

Co-authorship network of co-authors of Eriko Simamura

This figure shows the co-authorship network connecting the top 25 collaborators of Eriko Simamura. A scholar is included among the top collaborators of Eriko Simamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eriko Simamura. Eriko Simamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Simamura, Eriko, Tomohiro Arikawa, Takayuki Ikeda, et al.. (2015). Melanocortins Contribute to Sequential Differentiation and Enucleation of Human Erythroblasts via Melanocortin Receptors 1, 2 and 5. PLoS ONE. 10(4). e0123232–e0123232. 15 indexed citations
2.
Simamura, Eriko, Hiroki Shimada, T. Arai, et al.. (2015). The Suppression of Maternal–Fetal Leukemia Inhibitory Factor Signal Relay Pathway by Maternal Immune Activation Impairs Brain Development in Mice. PLoS ONE. 10(6). e0129011–e0129011. 28 indexed citations
3.
Arikawa, Tomohiro, Eriko Simamura, Hiroki Shimada, et al.. (2014). Significance of sugar chain recognition by galectins and its involvement in disease‐associated glycosylation. Congenital Anomalies. 54(2). 77–81. 6 indexed citations
4.
Arikawa, Tomohiro, Eriko Simamura, Hiroki Shimada, et al.. (2012). Expression pattern of Galectin 4 in rat placentation. Placenta. 33(10). 885–887. 13 indexed citations
5.
Simamura, Eriko, Hiroki Shimada, Hiroki Shoji, Hiroki Otani, & Toshihisa Hatta. (2011). Effects of melanocortins on fetal development. Congenital Anomalies. 51(2). 47–54. 15 indexed citations
6.
Simamura, Eriko, et al.. (2010). Maternal Leukemia Inhibitory Factor (LIF) Promotes Fetal Neurogenesis via a LIF-ACTH-LIF Signaling Relay Pathway. Endocrinology. 151(4). 1853–1862. 40 indexed citations
7.
Shimada, Hiroki, Kei‐Ichi Hirai, Eriko Simamura, et al.. (2009). Paraquat Toxicity Induced by Voltage-dependent Anion Channel 1 Acts as an NADH-dependent Oxidoreductase. Journal of Biological Chemistry. 284(42). 28642–28649. 22 indexed citations
8.
Simamura, Eriko, Hiroki Shimada, Toshihisa Hatta, & Kei‐Ichi Hirai. (2008). Mitochondrial voltage-dependent anion channels (VDACs) as novel pharmacological targets for anti-cancer agents. Journal of Bioenergetics and Biomembranes. 40(3). 213–217. 66 indexed citations
9.
Simamura, Eriko, Hiroki Shimada, Yasuhito Ishigaki, et al.. (2008). Bioreductive activation of quinone antitumor drugs by mitochondrial voltage-dependent anion channel 1. Anatomical Science International. 83(4). 261–266. 28 indexed citations
10.
Higashi, Nobuaki, Hiroki Shimada, Eriko Simamura, & Toshihisa Hatta. (2008). Right vertebral artery as the fourth branch of the aortic arch. Anatomical Science International. 83(4). 314–318. 13 indexed citations
12.
Koyama, Junko, Izumi Morita, Norihiro Kobayashi, et al.. (2006). Antiallergic Activity of Aqueous Extracts and Constituents of Taxus yunnanensis. Biological and Pharmaceutical Bulletin. 29(11). 2310–2312. 19 indexed citations
13.
Desmond, Julian C., Hiroshi Kawabata, Carsten Müller‐Tidow, et al.. (2005). The synthetic furanonaphthoquinone induces growth arrest, apoptosis and differentiation in a variety of leukaemias and multiple myeloma cells. British Journal of Haematology. 131(4). 520–529. 15 indexed citations
14.
Simamura, Eriko, Kei‐Ichi Hirai, Hiroki Shimada, Jiehong Pan, & Junko Koyama. (2003). Mitochondrial damage prior to apoptosis in furanonaphthoquinone treated lung cancer cells. Cancer Detection and Prevention. 27(1). 5–13. 14 indexed citations
15.
Hirai, Kei‐Ichi, et al.. (2002). Alpha-Tocopherol Protects Cultured Human Cells from the Acute Lethal Cytotoxicity of Dioxin. International Journal for Vitamin and Nutrition Research. 72(3). 147–153. 12 indexed citations
16.
Shimada, Hiroki, et al.. (2002). Paraquat detoxicative system in the mouse liver postmitochondrial fraction. Archives of Biochemistry and Biophysics. 402(1). 149–157. 17 indexed citations
17.
Pan, Jiehong, et al.. (2000). Induced apoptosis and necrosis by 2-methylfuranonaphthoquinone in human cervical cancer HeLa cells.. PubMed. 24(3). 266–74. 9 indexed citations
18.
Shimada, Hiroki, Kei‐Ichi Hirai, Eriko Simamura, & Jiehong Pan. (1998). Mitochondrial NADH–Quinone Oxidoreductase of the Outer Membrane Is Responsible for Paraquat Cytotoxicity in Rat Livers. Archives of Biochemistry and Biophysics. 351(1). 75–81. 72 indexed citations
19.
Takegami, Tsutomu, Eriko Simamura, Kei‐Ichi Hirai, & Junko Koyama. (1998). Inhibitory effect of furanonaphthoquinone derivatives on the replication of Japanese encephalitis virus. Antiviral Research. 37(1). 37–45. 31 indexed citations
20.
Pan, Jing, et al.. (1997). Mitochondrial damage by a new antitumour agent furanonaphthoquinone derivative in human cervical cancer HeLa cells. Journal of Electron Microscopy. 46(2). 181–187. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026